Vaccinating Pregnant & Lactating Patients Against COVID-19

Excerpts from:

American College of Obstetrics & Gynecology Practice Advisory:

Vaccinating Pregnant and Lactating Patients Against COVID-19

December 13, 2020

    • On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNtech mRNA vaccine (BNT162b2) for use in individuals age 16 years and older as a 2-dose regimen given 3 weeks apart. This vaccine has shown to be 95% effective at preventing COVID-19 illness after the second dose.
    • On December 12, 2020, after an explicit, evidence-based review of all available data, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years for the prevention of COVID-19 illness.
    • ACOG recommends that COVID-19 vaccines should not be withheld from pregnant individuals who meet the criteria for vaccination based on ACIP-recommended priority groups.
    • COVID-19 vaccines should be offered to lactating individuals similar to non-lactating individuals when they meet the criteria for receipt of the vaccine based on prioritization groups outlined by the ACIP.

https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19

 

Society for Maternal-Fetal Medicine (SMFM) Statement: SARS-CoV-2 Vaccination in Pregnancy

December 1, 2020

SMFM recommends that healthcare workers, who are considered prioritized for vaccination, be offered the vaccine if pregnant. A report by the National Academies of Sciences, Engineering, and Medicine entitled Framework for Equitable Allocation of COVID-19 Vaccine recommends that high-risk workers in health facilities or first responders should be among the first to receive the vaccine.15 Although pregnant women are not explicitly targeted in this framework, pregnant and lactating women who are otherwise eligible should be offered the vaccine.

https://s3.amazonaws.com/cdn.smfm.org/media/2591/SMFM_Vaccine_Statement_12-1-20_(final).pdf

Experts in High-Risk Pregnancy Respond to the FDA’s Decision to Offer the Newly Approved COVID-19 Vaccine to Pregnant and Lactating People

December 11, 2020

SMFM strongly recommends that pregnant and lactating people have access to COVID-19 vaccines.

https://s3.amazonaws.com/cdn.smfm.org/media/2632/FDA_final.pdf